BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38514754)

  • 1. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma.
    Wang Y; Zhang Y; Li Y; Huang J
    Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 4 and its inhibitors in inflammatory diseases.
    Jin SL; Ding SL; Lin SC
    Chang Gung Med J; 2012; 35(3):197-210. PubMed ID: 22735051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDE4D phosphorylation: A coincidence detector integrating multiple signaling pathways.
    Mika D; Conti M
    Cell Signal; 2016 Jul; 28(7):719-24. PubMed ID: 26562185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma.
    Sahin Y
    Clin Exp Med; 2023 Jul; 23(3):841-851. PubMed ID: 35810257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDE4 subtypes in cancer.
    Hsien Lai S; Zervoudakis G; Chou J; Gurney ME; Quesnelle KM
    Oncogene; 2020 May; 39(19):3791-3802. PubMed ID: 32203163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing.
    Johnson KR; Nicodemus-Johnson J; Danziger RS
    BMC Evol Biol; 2010 Aug; 10():247. PubMed ID: 20701803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor.
    Keravis T; Monneaux F; Yougbaré I; Gazi L; Bourguignon JJ; Muller S; Lugnier C
    PLoS One; 2012; 7(1):e28899. PubMed ID: 22247763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues.
    Yougbare I; Morin C; Senouvo FY; Sirois C; Albadine R; Lugnier C; Rousseau E
    Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L441-50. PubMed ID: 21784969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pregnancy on PDE4 cAMP-specific phosphodiesterase messenger ribonucleic acid expression in human myometrium.
    Leroy MJ; Méhats C; Duc-Goiran P; Tanguy G; Robert B; Dallot E; Mignot TM; Grangé G; Ferré F
    Cell Signal; 1999 Jan; 11(1):31-7. PubMed ID: 10206342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mRNA encoding cAMP-specific phosphodiesterase isoforms in rat parotid glands.
    Imai A; Nashida T; Shimomura H
    Biochem Mol Biol Int; 1996 Dec; 40(6):1175-81. PubMed ID: 8988329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of 3',5'-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats.
    Cheng D; Ren J; Gillespie DG; Mi Z; Jackson EK
    Hypertension; 2010 Dec; 56(6):1096-101. PubMed ID: 20975032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.
    Richter W; Jin SL; Conti M
    Biochem J; 2005 Jun; 388(Pt 3):803-11. PubMed ID: 15717866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
    Dong W; Du D; Huang H
    Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterase isoforms in human basophils and mast cells.
    Eskandari N; Tashrifi F; Bastan R; Andalib A; Yousefi Z; Peachell PT
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):654-665. PubMed ID: 26781461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
    Zhang X; Meng X; Wang P; Luan C; Wang H
    Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D.
    Mori F; Pérez-Torres S; De Caro R; Porzionato A; Macchi V; Beleta J; Gavaldà A; Palacios JM; Mengod G
    J Chem Neuroanat; 2010 Sep; 40(1):36-42. PubMed ID: 20347962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.
    Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L
    J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.